Predicting Outcomes for MF/SS

Predicting Outcomes for MF/SS

Multiple prognostic variables were prospectively evaluated for 168 patients with advanced stage mycosis fungoides (MF) and Sézary syndrome (SS). Univariate…

More...
Farming and Risk of NHL

Farming and Risk of NHL

The Agricultural Health Study, undertaken in two states in the USA, evaluated farm characteristics, allergic symptoms and conditions among farmers…

More...
Bortezomib Use in MCL

Bortezomib Use in MCL

In this phase III trial, 487 patients with newly diagnosed mantle cell lymphoma who were not eligible or not considered…

More...
MCL and miR-18b

MCL and miR-18b

Analysis of diagnostic mantle cell lymphoma (MCL) samples from the Nordic MCL2 (n= 74) and Nordic MCL3 (n = 94)…

More...
Frontpage Slideshow | Copyright © 2006-2014 JoomlaWorks Ltd.

Healthcare Matters

  • 1
  • 2
  • 3
Prev Next

Highlights from the 2015 T-Cell Lymphoma …

Highlights from the 2015 T-Cell Lymphoma Forum

The seventh annual T-Cell Lymphoma Forum was held in San Francisco at the end of January. It provided a forum for researchers, scientists and clinicians from around the world to come together to provide updates and latest findings in molecular pathogenesis as well as potential treatment options for patients with peripheral T-cell lymphomas (PTCLs), cutaneous T-cell lymphomas (CTCLs) and natural killer (NK) T-cell lymphomas (TCLs).

Read more

A Peek at OHLB Kraujas (Lithuania)

A Peek at OLHB Kraujas (Lithuania)

The impetus for the founding of OHLB Kraujas (Oncohaematological Patients’ Association of Blood) in 2002 was the need to improve the availability of new therapies in Lithuania.

“Patients and doctors formed this community so there would be a voice to say that we need new medicines, we need modern medicines, we need innovations,” said Karolis Azukatis who helps out on many of the different projects undertaken by OHLB Kraujas.

Read more

A Peek at Group Nexus Japan

A Peek at Group Nexus Japan

Until 2001, patients with lymphoma did not have their own patient support group in Japan. That changed when the mother of one of the founders of Group Nexus Japan was receiving treatment for lymphoma as she thought she should start a group that focused on lymphomas only rather than blood disorders in general in order to support those patients.

Read more

 KYN4   facebook2 twitter2 youtube1

Latest Lymphoma News

  • A Look at Biosimilars: An Update

    Much discussion on the topic of biosimilars and the many different aspects that come into play has taken place. 


    Read more ...
  • Analysing Outcomes in MCL

    An analysis of outcomes in patients with mantle cell lymphoma (MCL) following failure of first-line treatment was undertaken.


    Read more ...

What's Happening Around the World

  • A Peek at Flute of Light (Israel)

    Until recently, patients with either lymphoma or most leukaemias living in Israel did not have a patient support group but that’s changing thanks to the efforts of Giora Sharf, the director of Flute of Light, and his team.

    Read more ...  
  • A Peek at the IWMF

    This is the second in a series of articles examining the work undertaken by patient organisations to help those affected by WM.

    Waldenstrom’s macroglobulinaemia (WM) is a rare, slow growing blood cancer.

    Read more ...  

Research

  • Value of Biopsy Data in HL

    The diagnostic and relapse biopsies, as well as clinical outcome data were compared in this study to determine the biology associated with resistance to first-line therapy in Hodgkin lymphoma (HL), as well as identify prognostic markers. Read more ...  

  • BV Improves Outcomes in HL

    Results from the AETHERA Trial, a phase III, randomised, double-blind, placebo controlled, multicentre study, showed that the addition of brentuximab vedotin (BV) following autologous stem cell transplant (ASCT) resulted in longer progression-free survival (PFS) compared with best supportive care in those with relapsed or refractory Hodgkin lymphoma (HL).

    Read more ...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

Global Database Search

IN THE NODE

Updates